These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24713633)

  • 1. BMP pathway regulation of and by macrophages.
    Talati M; West J; Zaynagetdinov R; Hong CC; Han W; Blackwell T; Robinson L; Blackwell TS; Lane K
    PLoS One; 2014; 9(4):e94119. PubMed ID: 24713633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
    Hagen M; Fagan K; Steudel W; Carr M; Lane K; Rodman DM; West J
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1473-9. PubMed ID: 17322283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
    Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W
    BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.
    Hansmann G; de Jesus Perez VA; Alastalo TP; Alvira CM; Guignabert C; Bekker JM; Schellong S; Urashima T; Wang L; Morrell NW; Rabinovitch M
    J Clin Invest; 2008 May; 118(5):1846-57. PubMed ID: 18382765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH.
    Tada Y; Majka S; Carr M; Harral J; Crona D; Kuriyama T; West J
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1556-63. PubMed ID: 17369292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
    Upton PD; Davies RJ; Tajsic T; Morrell NW
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.
    Ihida-Stansbury K; McKean DM; Lane KB; Loyd JE; Wheeler LA; Morrell NW; Jones PL
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L694-702. PubMed ID: 16782755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trapping of BMP receptors in distinct membrane domains inhibits their function in pulmonary arterial hypertension.
    Jiang Y; Nohe A; Bragdon B; Tian C; Rudarakanchana N; Morrell NW; Petersen NO
    Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L218-27. PubMed ID: 21622843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
    PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic and molecular consequences of endothelial Bmpr2 mutation.
    Majka S; Hagen M; Blackwell T; Harral J; Johnson JA; Gendron R; Paradis H; Crona D; Loyd JE; Nozik-Grayck E; Stenmark KR; West J
    Respir Res; 2011 Jun; 12(1):84. PubMed ID: 21696628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A.
    Wang D; Prakash J; Nguyen P; Davis-Dusenbery BN; Hill NS; Layne MD; Hata A; Lagna G
    J Biol Chem; 2012 Aug; 287(33):28067-77. PubMed ID: 22718766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Miyagawa K; Shi M; Chen PI; Hennigs JK; Zhao Z; Wang M; Li CG; Saito T; Taylor S; Sa S; Cao A; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2019 Jan; 124(2):211-224. PubMed ID: 30582451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.